FC
BMRN icon

FORA Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

FORA Capital’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,762
Closed -$543K – 441
2025
Q4 		$543K Buy
+3,762
New +$205K 0.07% 286
2025
Q3 		– Sell
-9,414
Closed -$517K – 495
2025
Q2 		$517K Buy
9,414
+4,389
+87% +$258K 0.06% 324
2025
Q1 		$355K Buy
5,025
+1,800
+56% +$121K 0.04% 380
2024
Q4 		$212K Sell
3,225
-22,174
-87% -$1.49M 0.02% 346
2024
Q3 		$1.79M Buy
25,399
+16,926
+200% +$1.41M 0.21% 141
2024
Q2 		$698K Sell
8,473
-19,350
-70% -$1.61M 0.09% 255
2024
Q1 		$2.43M Buy
27,823
+5,822
+26% +$521K 0.2% 135
2023
Q4 		$2.12M Buy
+22,001
New +$1.95M 0.18% 153
2023
Q1 		– Sell
-7,648
Closed -$791K – 527
2022
Q4 		$791K Sell
7,648
-847
-10% -$79.5K 0.13% 194
2022
Q3 		$720K Buy
+8,495
New +$756K 0.14% 203
2022
Q1 		– Sell
-3,920
Closed -$346K – 518
2021
Q4 		$346K Buy
+3,920
New +$323K 0.13% 205
2021
Q3 		– Sell
-16,030
Closed -$1.34M – 422
2021
Q2 		$1.34M Buy
+16,030
New +$1.27M 0.25% 102
2020
Q2 		– Sell
-11,805
Closed -$998K – 911
2020
Q1 		$998K Buy
+11,805
New +$1.02M 0.22% 121

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FORA Capital's BMRN Position: Q1 2026 in Review

FORA Capital sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2026, closing a stake of 3,762 shares — an estimated $543K sold.

FORA Capital first reported a position in BMRN in Q1 2020 and held it in 13 quarters. The position peaked at $2.43M in Q1 2024. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • FORA Capital reported no remaining BioMarin Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • FORA Capital sold 3,762 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $543K.
  • FORA Capital first reported a position in BioMarin Pharmaceuticals in Q1 2020 and held it in 13 quarters.
  • FORA Capital's BioMarin Pharmaceuticals position peaked at $2.43M in Q1 2024.
  • 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.